[go: up one dir, main page]

WO2001078651A3 - Methode de traitement d'un patient atteint de neoplasie a l'aide d'un inhibiteur de topoisomerase i - Google Patents

Methode de traitement d'un patient atteint de neoplasie a l'aide d'un inhibiteur de topoisomerase i Download PDF

Info

Publication number
WO2001078651A3
WO2001078651A3 PCT/US2001/011865 US0111865W WO0178651A3 WO 2001078651 A3 WO2001078651 A3 WO 2001078651A3 US 0111865 W US0111865 W US 0111865W WO 0178651 A3 WO0178651 A3 WO 0178651A3
Authority
WO
WIPO (PCT)
Prior art keywords
inhibitor
treating
topoisomase
neoplasmin
neoplasia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/011865
Other languages
English (en)
Other versions
WO2001078651A2 (fr
Inventor
Rifat Pamukcu
Joseph Lobacki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cell Pathways Inc
Original Assignee
Cell Pathways Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell Pathways Inc filed Critical Cell Pathways Inc
Priority to EP01928470A priority Critical patent/EP1278519A4/fr
Priority to AU2001255322A priority patent/AU2001255322A1/en
Publication of WO2001078651A2 publication Critical patent/WO2001078651A2/fr
Publication of WO2001078651A3 publication Critical patent/WO2001078651A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Méthode de traitement d'un patient atteint de néoplasie à l'aide d'un traitement adjuvant reposant sur l'utilisation d'un inhibiteur de topoisomérase I.
PCT/US2001/011865 2000-04-12 2001-04-12 Methode de traitement d'un patient atteint de neoplasie a l'aide d'un inhibiteur de topoisomerase i Ceased WO2001078651A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP01928470A EP1278519A4 (fr) 2000-04-12 2001-04-12 Methode de traitement d'un patient atteint de neoplasie a l'aide d'un inhibiteur de topoisomerase i
AU2001255322A AU2001255322A1 (en) 2000-04-12 2001-04-12 Method for treating a patient with neoplasia by treatment with a topoisomerase iinhibitor

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54813500A 2000-04-12 2000-04-12
US09/548,135 2000-04-12

Publications (2)

Publication Number Publication Date
WO2001078651A2 WO2001078651A2 (fr) 2001-10-25
WO2001078651A3 true WO2001078651A3 (fr) 2002-03-14

Family

ID=24187563

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/011865 Ceased WO2001078651A2 (fr) 2000-04-12 2001-04-12 Methode de traitement d'un patient atteint de neoplasie a l'aide d'un inhibiteur de topoisomerase i

Country Status (3)

Country Link
EP (1) EP1278519A4 (fr)
AU (1) AU2001255322A1 (fr)
WO (1) WO2001078651A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001275228A1 (en) * 2000-06-06 2001-12-17 Glaxo Group Limited Cancer treatment composition containing an anti-neoplastic agent and a pde4 inhibitor

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999049859A1 (fr) * 1998-03-28 1999-10-07 The Arizona Board Of Regents On Behalf Of The University Of Arizona Combinaison de dfmo et de sulindac dans la chimioprevention du cancer
US6200771B1 (en) * 1998-10-15 2001-03-13 Cell Pathways, Inc. Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5604233A (en) * 1994-04-28 1997-02-18 Bionumerik Pharmaceuticals, Inc. Lactone stable formulation of 7-ethyl camptothecin and methods for uses thereof
US6063818A (en) * 1996-06-13 2000-05-16 Cell Pathways Inc. Substituted benzylidene indenyl formamides, acetamides and propionamides

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999049859A1 (fr) * 1998-03-28 1999-10-07 The Arizona Board Of Regents On Behalf Of The University Of Arizona Combinaison de dfmo et de sulindac dans la chimioprevention du cancer
US6200771B1 (en) * 1998-10-15 2001-03-13 Cell Pathways, Inc. Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE CAPLUS [online] ARBUCK ET AL.: "An overview of topoisomerase I-targeting agents", XP002905166, accession no. STN Database accession no. 1998:677659 *
See also references of EP1278519A4 *
SEMIN. HEMATOL., vol. 35, no. 3, SUPPL. 4, 1998, pages 3 - 12 *

Also Published As

Publication number Publication date
EP1278519A4 (fr) 2003-05-07
EP1278519A2 (fr) 2003-01-29
WO2001078651A2 (fr) 2001-10-25
AU2001255322A1 (en) 2001-10-30

Similar Documents

Publication Publication Date Title
AU2001282717A1 (en) Cancer treatment by combination therapy
IL177598A0 (en) An apparatus for performing a treatment on a tissue
AU2001294604A1 (en) Improved radiation therapy treatment method
ZA200305126B (en) Methods of administering epothilone analogs for the treatment of cancer.
WO2007008700A3 (fr) Methode et dispositif de traitement tissulaire
MXPA03008691A (es) Metodo para tratamiento de enfermedades proliperativas usando inhibidores eg5.
MXPA03003632A (es) Metodo para tratamiento de tumores usando terapia de combinacion.
AU2001260880A1 (en) Pharmaceutical compounds for treating copd
AU2002336405A1 (en) Methods for treating deodorizer distillate
AU2003903387A0 (en) Combination therapy for treatment of neoplasia
AU2002218439A1 (en) Apparatus for treating body ailments
AU8873101A (en) A method for treating allergies using substituted pyrazoles
MXPA03006607A (es) Metodo combinado para tratar trastornos dependientes de hormonas.
MXPA02012907A (es) Procedimiento para encontrar compuestos que son adecuados para el tratamiento y/o la profilaxia de la obesidad.
AU2002217447A1 (en) Apparatus for lipolysis for aesthetic treatment
MXPA03007036A (es) Metodo de terapia para cancer.
AU751887B2 (en) Guide bar including stump treatment
AP2004003070A0 (en) The method of treating cancer.
AU9716001A (en) Guide bar including stump treatment
AU2002308642A1 (en) Methods for treating cancer
AP2001002248A0 (en) Method for treating COPD.
AU2149500A (en) Method for treating a patient with neoplasia by treatment with a paclitaxel derivative
WO2002083151A3 (fr) Compositions et procedes pour traiter un etat arthritique
WO2001078651A3 (fr) Methode de traitement d'un patient atteint de neoplasie a l'aide d'un inhibiteur de topoisomerase i
MXPA03004017A (es) Metodo para el tratamiento de inflamacion.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2001928470

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001928470

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2001928470

Country of ref document: EP